Provided by Tiger Trade Technology Pte. Ltd.

MABPHARM-B

0.495
+0.0408.79%
Volume:402.00K
Turnover:197.12K
Market Cap:2.04B
PE:42.93
High:0.495
Open:0.485
Low:0.485
Close:0.455
52wk High:0.880
52wk Low:0.400
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:3.27
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.012
ROE:46.40%
ROA:0.28%
PB:11.26
PE(LYR):42.93
PS:2.74

Loading ...

Mabpharm-B Maintains 4.12 Billion Issued Shares in April 2026; 72.67 Million Options Remain Outstanding

Bulletin Express
·
May 06

MABPHARM-B 2025财年营收大涨并实现扭亏为盈,聚焦核心抗体研发与全球拓展

Bulletin Express
·
Apr 27

Mabpharm announces annual general meeting

Reuters
·
Apr 27

Mabpharm Schedules 26 June 2026 AGM to Approve 2025 Results, Board Re-elections, Dual Share Mandates and New Articles

Bulletin Express
·
Apr 27

Mabpharm to Convene 26 June 2026 AGM; Board Seeks 10% Share Buyback and 20% Issuance Mandates

Bulletin Express
·
Apr 27

Mabpharm publishes 2025 annual report

Reuters
·
Apr 27

Mabpharm-B Monthly Return Indicates Unchanged Share Structure for March 2026

Bulletin Express
·
Apr 02

Mabpharm Proposes Amendments to Memorandum and Articles to Enable Treasury Shares and Electronic Meetings

Bulletin Express
·
Mar 26

Mabpharm proposes bylaw amendments; shareholder vote set for forthcoming AGM

Reuters
·
Mar 26

Mabpharm-B Reports Annual Profit Turnaround with CNY57.1 Million Net Income

Stock News
·
Mar 26

BRIEF-Mabpharm FY Profit And Total Comprehensive Income Attributable Rmb57.1 Million

Reuters
·
Mar 26

Mabpharm FY2025 revenue rises to CNY 646 million; profit climbs to CNY 57 million

Reuters
·
Mar 26

Mabpharm FY2025 profit rose to RMB57 million; revenue more than doubled to RMB646 million

Reuters
·
Mar 26

Mabpharm Ltd - FY Profit and Total Comprehensive Income Attributable RMB57.1 Mln

THOMSON REUTERS
·
Mar 26

Mabpharm FY Revenue RMB 646.1 Million

THOMSON REUTERS
·
Mar 26

MABPHARM-B (02181) Schedules 26 Mar 2026 Board Meeting to Approve FY2025 Results

Bulletin Express
·
Mar 12

Mabpharm schedules board meeting to approve annual results

Reuters
·
Mar 12

Mabpharm (02181) Releases February 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Mar 03

Mabpharm (2181) Issues Reminder on Electronic Dissemination of Corporate Communications

Bulletin Express
·
Feb 10

Mabpharm Limited (2181) Reminds Shareholders of Electronic Dissemination Arrangements

Bulletin Express
·
Feb 10